On 2025-05-08, Xilio Therapeutics, Inc. (XLO) announced earnings per share of $-0.18 for the fiscal quarter ending 2025-03-31, missing the average analyst estimate of $0.10.
The next expected annoucement date for quarterly earnings is 2025-08-14, with an average estimated earnings per share of $-0.10 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-08 | 2025-03-31 | $0.10 | $-0.18 |
| 2025-03-11 | 2024-12-31 | $-0.22 | $-0.20 |
| 2024-11-07 | 2024-09-30 | $-0.25 | $-0.22 |
| 2024-08-08 | 2024-06-30 | $-0.23 | $-0.24 |
| 2024-05-14 | 2024-03-31 | $-0.30 | $-0.59 |
| 2024-04-01 | 2023-12-31 | -- | $-0.64 |
| 2023-11-09 | 2023-09-30 | $-0.76 | $-0.61 |
| 2023-08-14 | 2023-06-30 | $-0.84 | $-0.70 |
| 2023-05-09 | 2023-03-31 | $-0.91 | $-0.83 |
| 2023-03-02 | 2022-12-31 | $-0.83 | $-0.82 |
| 2022-11-09 | 2022-09-30 | $-0.89 | $-0.72 |
| 2022-08-09 | 2022-06-30 | $-0.78 | $-0.90 |
| 2022-05-12 | 2022-03-31 | $-1.00 | $-0.78 |
| 2022-03-01 | 2021-12-31 | $-0.94 | $-0.98 |
| 2021-12-02 | 2021-09-30 | $-2.00 | $-21.27 |